| Subject: | FDA Issues Warning Letters To Bayer About Two Unapproved Aspirin Products |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 29 Oct 2008 - 10:00 am |
| On Oct. 28, 2008, the Food and Drug Administration (FDA) sent warning letters to Bayer HealthCare regarding two over-the-counter (OTC) products that combine aspirin with a dietary supplement into a single pill. The products are not approved by FDA. The two products are: Bayer Aspirin with Heart Advantage (Bayer Heart Advantage)-aspirin combined with phytosterols (a plant-based supplement also known as plant sterols) Bayer Women's Low Dose Aspirin + Calcium (Bayer Women's)-aspirin... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
